Clinical Trial Update: Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) [Phase 3]

View source ↗

Summary

Ipsen announced Phase 3 results for elafibranor in patients with primary biliary cholangitis; the study is listed as ACTIVE_NOT_RECRUITING with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Elafibranor

Snippet

Sponsor: Ipsen | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-09-05